Comments

Franklin Genomic Advancements ETF Stock Price, Quotes and Forecasts

HELXBATS
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$26.99
-0.14-0.51%
At close: -

Overview

NewsHoldingsDividendsShort Interest
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Sector
Healthcare
Region
US
AUM
10.85M
Fund Score

Franklin Genomic Advancements ETF Price, Quotes and Forecasts | BATS:HELX | Benzinga

Explore Franklin Genomic Advancements ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HELX.

Open$26.85
High$26.99
52 Wk High$33.98
AUM10.85M
Dividend-
Ex-Div Date-
Volume205
Market Cap$82.20B
Mgmt Fee0.5%
P/E Ratio35.48
Prev. Close$27.12
Low$26.85
52 Wk Low$23.74
Shares Out300.00K
Yield-
Div. Freq-
Avg. Volume Daily1.87K
Beta1.15
Avg. Expense Ratio0.5%
P/B Ratio4.30

Recent News

FAQ

Q

How do I buy Franklin Genomic Advancements ETF (HELX) stock?

A

You can purchase shares of Franklin Genomic Advancements ETF (BATS:HELX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Franklin Genomic Advancements ETF (HELX) competitors?

A

There are no as such competitors for Franklin Genomic Advancements ETF.

Q

What is the forecast, or price target, for Franklin Genomic Advancements ETF (HELX) stock?

A

There is no analysis for Franklin Genomic Advancements ETF to provide a consensus price target.

Q

What is the current price for Franklin Genomic Advancements ETF (HELX)?

A

The stock price for Franklin Genomic Advancements ETF (BATS: HELX) is $26.9857 last updated April 25, 2025 at 8:00 PM EDT.

Q

Does Franklin Genomic Advancements ETF (HELX) pay a dividend?

A

There are no upcoming dividends for Franklin Genomic Advancements ETF.

Q

When is Franklin Genomic Advancements ETF (BATS:HELX) reporting earnings?

A

Franklin Genomic Advancements ETF does not have any upcoming earnings scheduled.

Q

Is Franklin Genomic Advancements ETF (HELX) going to split?

A

There is no upcoming split for Franklin Genomic Advancements ETF.

Open$26.85
High$26.99
52 Wk High$33.98
AUM10.85M
Dividend-
Ex-Div Date-
Volume205
Market Cap$82.20B
Mgmt Fee0.5%
P/E Ratio35.48
Prev. Close$27.12
Low$26.85
52 Wk Low$23.74
Shares Out300.00K
Yield-
Div. Freq-
Avg. Volume Daily1.87K
Beta1.15
Avg. Expense Ratio0.5%
P/B Ratio4.30
About Franklin Templeton ETF Trust
Sector
N/A
Industry
N/A
Got Questions? Ask
What is HELX's 200-day MA?
What does HELX's DCF valuation show?
What is HELX's all-time high price?
What is HELX's all-time low price?
What is the Pivot support level for HELX?
Powered By
ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleMid Cap Growth
Fund InceptionFeb 25, 2020
Managers
Matthew J. Moberg
DefinitionMost of the stocks in this equity fund have average financial performance and average growth potential
Investment Policy
The Fund invests in equity securities inside and outside of the United States, including developing or emerging markets.
Top ETF Holdings
SymbolNameShare %
MEDPMedpace Holdings Inc3.52%
VRTXNvaesrtex Pharmaceutic...5.03%
REGNRegeneron Pharmaceutic...3.79%
DHRDanaher Corp.5.14%
TMOThermo Fisher Scientif...3.38%
KRYSKrystal Biotech Inc5.17%
LLYEli Lilly & Co.3.51%
KRSamsung Biologics Co L...3.67%
NTRANatera Inc5.54%
LNAstrazeneca Plc, ADR3.01%
UTHRUnited Therapeutics Co...3.18%
FFBiontech Se2.87%
CTVACorteva  Inc .2.89%

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved